Table 1: Baseline characteristics at enrollment and outcomes at 10 years after discharge.
Values are means ± standard deviation or number (%). Brain natriuretic peptide is shown as means ± standard error. ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; eGFR = estimated glomerular filtration rate.
Survivors without events (N = 32) Survivors with events (N = 24) Nonsurvivors (N = 28) P
Age, years 65 ±14 68 ±10 74 ±8 0.01
Men 21 (66%) 13 (54%) 15 (54%) 0.57
Medical history
Ischemic heart disease 13 (41%) 4 (17%) 13 (46%) 0.06
Atrial fibrillation 7 (23%) 12 (50%) 10 (36%) 0.11
Left ventricular ejection fraction, % 51 ±16 59 ±16 49 ±23 0.10
eGFR, ml/min/1.73 m2 66±19 60 ±18 46 ±21 0.01
Diabetes mellitus 5 (16%) 6 (25%) 12 (43%) 0.06
Hypertension 18 (56%) 10 (42%) 12 (43%) 0.46
Current smoker 7 (22%) 9 (38%) 8 (30%) 0.44
Medications
Beta-blocker 13 (41%) 10 (42%) 7 (25%) 0.35
ACE inhibitor/ARB 21 (66%) 11 (46%) 16 (57%) 0.33
Brain natriuretic peptide, pg/ml 145 ±25 222 ±43 357 ±65 <0.01
Left ventricular morphology
End-diastolic volume index, ml/m2 86 ±28 87 ±27 89 ±36 0.90
End-systolic volume index, ml/m2 45 ±28 38 ±22 49 ±33 0.34
Mass index, g/m2 143 ±35 142 ±45 139 ±50 0.94